LIPOCINE INC NEW - COM (LPCN)

CUSIP: 53630X104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
7,136,635
Share change
+2,834,983
Total reported value
$10,061,000
Put/Call ratio
21%
Price per share
$1.41
Number of holders
27
Value change
+$4,119,257
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 53630X104?
CUSIP 53630X104 identifies LPCN - LIPOCINE INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LIPOCINE INC NEW - COM (LPCN) as of Q3 2020

As of 30 Sep 2020, LIPOCINE INC NEW - COM (LPCN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,136,635 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., AMERIPRISE FINANCIAL INC, SABBY MANAGEMENT, LLC, Qube Research & Technologies Ltd, GEODE CAPITAL MANAGEMENT, LLC, MERCER GLOBAL ADVISORS INC /ADV, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, and RSM US WEALTH MANAGEMENT LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.